2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Blood Pressure, High in 8 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension is characterized by abnormal vascular contractility and function." | 1.32 | Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension. ( Loberg, RD; Northcott, CA; Watts, SW; Wehrwein, EA, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gandhi, H | 1 |
| Naik, P | 1 |
| Agrawal, N | 1 |
| Yadav, M | 1 |
| Zhang, L | 1 |
| Xie, P | 1 |
| Wang, J | 1 |
| Yang, Q | 1 |
| Fang, C | 1 |
| Zhou, S | 1 |
| Li, J | 1 |
| Benter, IF | 1 |
| Al-Rashdan, I | 1 |
| Juggi, JS | 1 |
| Yousif, MH | 1 |
| Akhtar, S | 1 |
| Loberg, RD | 2 |
| Northcott, CA | 4 |
| Watts, SW | 4 |
| Brosius, FC | 1 |
| Wehrwein, EA | 1 |
| Hayflick, JS | 1 |
| McCallum, RW | 1 |
| Hamilton, CA | 1 |
| Graham, D | 1 |
| Jardine, E | 1 |
| Connell, JM | 1 |
| Dominiczak, AF | 1 |
| Hayflick, J | 1 |
8 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Blood Pressure, High
| Article | Year |
|---|---|
Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; | 2016 |
Impaired peroxisome proliferator-activated receptor-gamma contributes to phenotypic modulation of vascular smooth muscle cells during hypertension.
Topics: Animals; Aorta; Cell Movement; Cell Proliferation; Chromones; Enzyme Inhibitors; Gene Expression Reg | 2010 |
Chronic treatment with LY294002, an inhibitor of phosphatidylinositol 3-kinase, attenuates ischemia/reperfusion-induced cardiac dysfunction in normotensive and hypertensive diabetic animals.
Topics: Animals; Cardiotonic Agents; Chromones; Coronary Vessels; Diabetes Mellitus, Experimental; Hypertens | 2013 |
PI3-kinase-induced hyperreactivity in DOCA-salt hypertension is independent of GSK-3 activity.
Topics: Aminophenols; Animals; Arteries; Chromones; Culture Techniques; Desoxycorticosterone; Enzyme Inhibit | 2003 |
Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension.
Topics: Amides; Animals; Arteries; Calcium; Chromones; Desoxycorticosterone; Enzyme Inhibitors; Hypertension | 2004 |
PI3-kinase upregulation and involvement in spontaneous tone in arteries from DOCA-salt rats: is p110delta the culprit?
Topics: Adenine; Animals; Aorta; Chromones; Class I Phosphatidylinositol 3-Kinases; Desoxycorticosterone; Di | 2004 |
Vascular responses to IGF-I and insulin are impaired in aortae of hypertensive rats.
Topics: Androstadienes; Animals; Aorta, Thoracic; Chromones; Endothelin-1; Enzyme Inhibitors; Female; Hypert | 2005 |
Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility.
Topics: Adenine; Animals; Aorta; Blotting, Western; Chromones; Dose-Response Relationship, Drug; Endothelium | 2005 |